Data brokers’ use of big data leads to questions about how best to protect consumers.
Supporters of legislation argue FDA will not cabin its regulatory power on its own.
New opinion highlights debate over the role of antitrust law in FCC disputes.
Debate rages on as Congress considers legislation to solve this problem.
Congress holds hearings on the role of import bans in licensing of standard essential patents.
Allegations in complaints befit a conspiracy novel - one that Apple argues is completely fictional.
Party-line vote moves forward bill that would change FCC processes.
The FDA's proposal to modernize generic drug approvals meets with broad support.
AT&T calls report "obviously one-sided" and questions whether its authors were "predisposed."
New "open Internet" regulations survive congressional challenge.